10 pending office actions • 4 clients
| Client (Assignee) | Pending OAs |
|---|---|
| Quest Diagnostics Investments LLC | 6 |
| Quest Diagnostics Investments LLC | 2 |
| Cleveland Heartlab, Inc. | 1 |
| Athena Diagnostics, Inc. | 1 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18794356 | METHODS FOR THE DIAGNOSIS OF BACTERIAL VAGINOSIS | Quest Diagnostics Investments LLC | WOOLWINE, SAMUEL C | 1681 | Non-Final OA | Aug 05, 2024 |
| 18520470 | HEMATOPOIETIC CELL PHENOTYPING USING CIRCULATING CELL-FREE MARKERS | Quest Diagnostics Investments LLC | GOUGH, TIFFANY MAUREEN | 1651 | Non-Final OA | Nov 27, 2023 |
| 17986339 | BORDETELLA DETECTION ASSAY | Quest Diagnostics Investments LLC | BERTAGNA, ANGELA MARIE | 1681 | Non-Final OA | Nov 14, 2022 |
| 17977733 | METHODS FOR DETECTING CYSTIC FIBROSIS MUTATIONS USING MITRA TIP EXTRACTION | Quest Diagnostics Investments LLC | FLINDERS, JEREMY C | 1684 | Non-Final OA | Oct 31, 2022 |
| 17977976 | METHODS FOR QUANTITATION OF INSULIN LEVELS BY MASS SPECTROMETRY | Quest Diagnostics Investments LLC | SODERQUIST, ARLEN | 1797 | Final Rejection | Oct 31, 2022 |
| 17942927 | METHODS FOR DETECTING DNA MUTATIONS USING MITRA TIP EXTRACTION | Quest Diagnostics Investments LLC | FLINDERS, JEREMY C | 1684 | Final Rejection | Sep 12, 2022 |
| 17588925 | Lp-PLA2 ASSAYS AND COMPOSITION WITH DETERGENT | Cleveland Heartlab, Inc. | MARTIN, PAUL C | 1653 | Non-Final OA | Jan 31, 2022 |
| 17610044 | MULTIPLEX ASSAY FOR DETERMINING THE ß-AMYLOID 42/40 RATIO IN HUMAN PLASMA SPECIMENS | Quest Diagnostics Investments LLC | IVICH, FERNANDO NMN | 1678 | Non-Final OA | Nov 09, 2021 |
| 17427014 | METHODS FOR DETECTING LEGIONELLA | Quest Diagnostics Investments LLC | HORTH, LISA ANNE | 1681 | Final Rejection | Jul 29, 2021 |
| 17006360 | PATHOGENICITY SCORING SYSTEM FOR HUMAN CLINICAL GENETICS | Athena Diagnostics, Inc. | HAYES, JONATHAN EDWARD | 1685 | Non-Final OA | Aug 28, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial